drugset / Trial / NCT03124355

Vagal Stimulation in POTS

NCT03124355

Phase 1 Active not recruiting 11 enrolled Vanderbilt University Medical Center
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to investigate how the electrical stimulation of a nerve in the skin of the earlobe (transcutaneous vagal nerve stimulation), alone or in combination with two medications (galantamine and pyridostigmine), affects the way the autonomic (involuntary) nervous system controls heart rhythm, symptoms on standing, and inflammatory markers in female patients with postural tachycardia syndrome (POTS). The study consists of 2 parts: a screening (1-2 study days), and 3 testing days. The study will take 5 days total and about 16 participants will be screened for the study. The investigators estimate 13 will be eligible to participate in all of the study days.

Timeline

Start
2017-09-30
Primary completion
2027-06
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule 8 mg Oral
Subject Pyridostigmine Small molecule 30 mg Oral